New Approaches to Targeted Therapy in Melanoma

SIMPLE SUMMARY: Immune checkpoint inhibitors and BRAF/MEK inhibitors are the cornerstone of treatment for melanoma; however, primary and acquired resistance to these therapies highlight an ongoing, unmet need to develop novel treatment modalities. The emergence of monoclonal antibodies and small mol...

Descripción completa

Detalles Bibliográficos
Autores principales: Fernandez, Manuel Felipe, Choi, Jacob, Sosman, Jeffrey
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10296143/
https://www.ncbi.nlm.nih.gov/pubmed/37370834
http://dx.doi.org/10.3390/cancers15123224

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10296143/
https://www.ncbi.nlm.nih.gov/pubmed/37370834
http://dx.doi.org/10.3390/cancers15123224

Ejemplares similares